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Abstract: 
Background The EQ-5D instrument has five dimensions.  This paper reports on the effects of 
manipulating: (a) the order in which the five dimensions are presented (appearing first vs last); 
(b) splitting of the composite dimensions (Pain or Discomfort; and Anxiety or Depression); 
and (c) removing or bolting off one of the five EQ-5D dimensions at a time.  The effects were 
examined in two contexts: (1) self-reporting health, and (2) health state valuations.
Methods Three different Types of discrete choice experiments (DCE) including a duration 
attribute were designed.  An online survey with 12 sub-Types, each with 10 DCE tasks, was 
designed, and completed by 2,494 members of the UK general public.  
Results  Of the three manipulations in the self-reporting context, only (b) splitting Anxiety or 
Depression had a significant effect.  In the health state valuation context, (b) splitting level 5 
Pain or Discomfort (relative to Pain) and splitting level 5 Anxiety or Depression (relative to 
Anxiety) had significant effects, as did (c) bolting off dimensions.
Conclusions We find that the values given to certain health dimensions are sensitive to the way 
in which it is described, and the other health dimensions presented. Of particular interest is the 
effect of splitting composite dimensions: a given EQ-5D(-5L) profile may mean different things 
depending on whether the profile is used to self-report ones health or to value hypothetical 
states, so that the health state values EQ-5D(-5L) in population tariffs may not correspond to 
the states that patients self-report themselves in.  
[246wds]
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Introduction
The EQ-5D(-5L) is a widely used generic instrument consisting of a health state classification 
system and preference-based weights [1,2].  The preference-based weights are derived using 
health state valuation methods such as the Time Trade-Off (TTO; [3]) or Discrete Choice 
Experiments (DCE [4]), and the classification system is used to assign these weights to different 
health states that patients classify themselves in.  The five dimensions (Mobility (M); Self-Care 
(SC); Usual Activities (UA); Pain or Discomfort (PD); and Anxiety or Depression (AD)) are 
presented in a set order, and the latter two are composite dimensions of two closely related 
but different aspects of health.  This paper explores three issues related to the EQ-5D 
classification system, across two contexts: one for self-reporting health and the other for 
valuing hypothetical health states.
The first issue concerns the order in which the dimensions are presented.  The psychology 
literature has discussed recency and primacy biases, broadly described as serial position 
effects [5-7].  A recency bias represents a situation where a respondent remembers and 
processes more recent information more efficiently than earlier information [8].  On the other 
hand, a primacy bias occurs where a respondent might recall and process the information listed 
first rather than last [9].  In the context of self-reporting health, serial position effects may 
concern the levels of the dimensions: a primacy effect would suggest that respondents focus on 
the no problems level of a given health dimension because it is mentioned first; or a recency 
effect would make them more likely to focus on extreme problems because it appears last.  
As each dimension is presented separately as a set of five levels for which one is chosen, the 
overall order of the dimensions may not be explained by a serial position effect.  On the other 
hand, in the context of health state valuations, where a health state is presented as a list of 
items, the order in which the dimensions of health are described could impact the way in which 
respondents process the information in line with recency or primacy effects [10].  Previous 
studies have found mixed effects.  Mulhern et al [11] applied three different EQ-5D-5L 
dimension orders in TTO and DCE (without duration) and found that magnitude of the 
dimension coefficients varies across the different dimension orderings but without a clear 
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pattern. Mulhern et al [12] used online DCETTO (with duration; see below) to compare the 
standard and systematically manipulated orderings of EQ-5D-5L dimensions at the between- 
and within-subject level and found little effect. Similarly, Norman et al [13] found that varying 
the dimension order in a valuation of the cancer specific EORTC QLU-C10D had little effect on 
level coefficients. In a study for monetary valuation, Kjaer et al [14] found that if the price 
attribute was presented last respondents provided lower willingness to pay  in DCETTO, this 
would correspond to the position of the duration attribute relative to the health state.  
Another psychological effect of importance in the completion of questionnaires and DCE tasks 
is linked to the way in which information is attended to and cognitively processed.  This is also 
affected by the way in which the information is presented, and the amount of information 
included. For example, Hensher [15] found that the amount and structure of the information 
provided in a DCE impacted the way in which that information was processed and responded 
to. This effect is tested in two further manipulations of the EQ-5D as described below.
The second issue concerns dimensions including more than one concept  composite 
dimensions.  The PD and AD dimensions are each effectively a combination of two separate but 
related items which may lead to ambiguity.  Furthermore, such composite dimensions have 
different meanings in the self-reporting and health state valuation contexts [16].  For example, 
it is entirely logical to use moderate Pain or Discomfort to self-report moderate Pain with no 
Discomfort, no Pain with moderate Discomfort, or moderate Pain alongside moderate 
Discomfort.  However, where a respondent is asked to value moderate Pain or Discomfort, it 
would be incorrect to imagine moderate Pain alongside moderate Discomfort.  This would 
suggest a mismatch between the state that people self-report and the state that a value is 
predicted for.   There has only been limited empirical examination of this issue [17].
The third issue regards removing, or bolting off dimensions.  This is motivated by research on 
bolt-on dimensions to the EQ-5D(-5L) (e.g. [18]), which addresses the fact that the EQ-5D(-5L) 
only covers a limited range of health related quality of life (HRQL) dimensions and the concern 
that there may be contexts where information on other dimensions of HRQL is important not 
only for health care resource allocation decisions across clinical and public health, but also for 
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health outcomes research more widely.  In the context of self-report, if respondents feel that 
important dimensions are missing, they may report this information in their response to an 
existing dimension, so that the response to the original dimension depends on the other items 
included.[19]  In the context of health state valuation, firstly, there may be circumstances 
where there is more than one missing dimension that needs adding to EQ-5D(-5L), but there 
is a limit to the number of dimensions that can reasonably be included in health state valuation 
studies.  One way to deal with this in valuation studies is by introducing overlap across 
dimensions so that certain attributes have the same level within choice sets, thus in effect, 
reducing the number of attributes that respondents need to consider [20].  However doing this 
reduces the efficiency of the study design, and another way to circumvent this could be by 
bolting off one or more of the existing EQ-5D(-5L) dimensions that may be less relevant to 
particular conditions.  Secondly, the bolt-on literature has found that providing information that 
there is no problem in some additional dimension can make the state significantly better than 
the original EQ-5D state without this information [18,19,21].  Bolting off will allow a test of 
whether the same is applicable to the existing dimensions of the EQ-5D(-5L).  We are aware of 
no other bolt-off studies.
Thus, this study aims to examine the effects of: the order in which the EQ-5D dimensions are 
presented (aim a), splitting up the two composite EQ-5D dimensions (PD and AD) (aim b), and 
bolting off one EQ-5D dimension at a time (aim c), on peoples self-reporting of actual health 
and the valuation of hypothetical states.  There are six corresponding null hypotheses.  First, 
regarding self-reported health, 
a1. the proportion of people reporting level 1 in a given dimension is not affected by 
whether the dimension appears first or last;
b1. the proportion of people who self-report level 1 in a composite dimension is no 
different from the proportion of people who self-report level 1 in both sub-dimensions 
when the dimension is decomposed; and
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c1. the proportion of people reporting problems in a dimension is unaffected by another 
dimension being bolted off.
Second, regarding health state valuation, 
a2. the disutility of a dimension is unaffected by whether it is presented first or last;
b2. the disutility associated with a composite dimension is no larger than the disutility 
associated with either sub-dimension at the same level; and
c2. the disutility of a dimension is unaffected by another dimension being bolted off.
An online survey of the UK general public using DCETTO was conducted to address these.
Methods
Survey design, recruitment and the sample
Respondents were recruited from a commercial internet panel (IPSOS Observer).  Quota 
sampling was used to ensure respondents were representative of the UK general population for 
age (across five age groupings from 18 to 65) and gender.
First, potential respondents accessed the survey webpage, read detailed project information 
and consented to take part.  Those consenting to participate were then randomized to one 
survey variant and completed demographic and self-reported health status, ONS wellbeing 
questions and the relevant variant of the EuroQol Instrument (with five levels) for their own 
health based on the variant they were randomized to. They were then presented with 
information about the DCETTO tasks.  These are DCE with duration as one of the attributes [22], 
and the naming reflects the fact that each choice requires respondents to trade-off between 
the health-related quality of life and the length of survival  as in a TTO.  The DCETTO included 
details about the relevant EQ-5D-3/5L health dimensions (see below), and instructions to 
imagine: that they would experience each health state for the period shown without relief or 
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treatment; that death would be very swift and completely painless; and that they would have 
no other health problems besides what was indicated. This was followed by ten DCETTO tasks.  
Respondents were screened out if they completed the survey in less than the minimum 
completion time of 2 minutes, which was set based on judgment of the research team following 
a soft launch phase.  No maximum limit was set.
Experimental design: Overall
The DCETTO questions were based on EQ-5D-3/5L (with adaptations to address the relevant 
manipulations, as detailed below).  The 3/5L indicates that it uses three of the five levels (1, 3, 
and 5) of EQ-5D-5L.  The full EQ-5D-5L was not used for the valuation tasks in order to reduce 
the number of possible states to be valued.    
The DCETTO scenarios consisted of you living in a particular state for one of three levels of 
Duration (6, 8, and 10 years) followed by death.  The three levels of Duration were selected to 
include 10 years (a common value used in health state valuation research), and with narrower 
gaps than in previous DCETTO studies (see for example [22], which used 1, 5, and 10 years).  The 
narrower gap was chosen, because a 10-fold difference in duration across a choice pair would 
mean that the scenario with the longer duration would be selected almost regardless of the 
state (provided both states are better than being dead)  narrower gaps would allow more 
trade-offs between the state and duration.   
The analysis of DCETTO data involves modeling the pairwise choice data in terms of interactions 
between the health state and Duration [22].   The main DCETTO design is called Type III. (Types I 
and II addressed unrelated research questions and are reported in [23].)  Type III involves 11 
parameters (interactions between each of the EQ-5D-3/5L dummies and continuous Duration 
5x(3-1)x1=10, plus continuous Duration).  However, to allow for possible further analysis 
including EQ-5D-3/5L main effects and quadratic Duration, the design had 32 parameters (the 
above 11, plus main effects for EQ-5D-3/5L dummies 5x(3-1), interactions between these and 
Duration squared, and Duration squared).  Sixty choice sets were selected based on a D-
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efficient design with zero prior values using Ngene [24], and allocated to six blocks of ten tasks.  
Target sample size for Type III was set at 700.
Experimental design for aim (a)
For aim (a), four sub-Types IIIa to IIId were created by varying the order in which the DCETTO 
attributes were presented. Even if the position of Duration is restricted to either precede or 
follow the health state dimensions, there are still 240 possible orderings (2x5x4x3x2x1).  From 
these, the following particular four combinations were chosen: Type IIIa moved Mobility to the 
last of the EQ-5D dimensions, maintained the ordering of the remaining four dimensions, and 
kept Duration last (to understand how important the first dimension is); Type IIIb treated the 
first three dimensions (that are more functioning-based) and the last two dimensions (the are 
more symptoms-based) as blocks and swapped them round, and kept Duration last; Type IIIc 
reversed the ordering of the five EQ-5D dimensions (to test the impact of overall order), but 
kept Duration last; and Type IIId kept the EQ-5D ordering, but placed Duration first (to test the 
importance of the position of duration on the magnitude of its coefficient).  Target sample size 
for the sub-Types IIIa to IIId was set at 150 each.
Experimental design for aim (b)
For aim (b), the composite dimensions were split to form EQ-6D-3/5L.  One sub-variant of this 
(IVa) split Pain/Discomfort into a Pain dimension and a Discomfort dimension; the other sub-
variant (IVb) split Anxiety/Depression into an Anxiety dimension and a Depression dimension  
all else remained unchanged. This involves 13 parameters (interactions between each of the 
EQ-6D-3/5L level dummies and continuous Duration 6x(3-1)x1=12, plus continuous Duration).  
To allow further analyses in line with Type III, the Type IV design had 38 parameters (12x3+2).  
For each sub-Type, IVa and IVb, 60 choice sets were selected based on a D-efficient design with 
zero prior values, and allocated to six blocks of ten DCETTO tasks.  Target sample size for the sub-
Types IVa to IVb was set at 225 each.
Experimental design for aim (c)
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For aim (c), one dimension was bolted off to form EQ-4D-3/5L.  This has five sub-variants: one 
that dropped Mobility; another that dropped Self-Care; and so on.  Duration always appeared 
last.  This involves nine parameters (interactions between each of the EQ-4D-3/5L level 
dummies and continuous Duration 4x(3-1)x1=8, plus continuous Duration).  To allow further 
analyses, the Type V design had 26 parameters (8x3+2).  For each sub-Type, Va to Ve, 60 choice 
sets were selected based on a D-efficient design with zero prior values, and allocated to six 
blocks of ten DCETTO tasks. Target sample size for the sub-Types Va to Ve was set at 150 each.
Analysis 
Self-reported health by sub-Type were summarised as bar charts, and differences in 
proportions reporting any problems in a given dimension were compared relative to Type III.  In 
addition, for Type IV, cross-tables were used to examine the distribution of responses across 
the composite and corresponding split dimensions.
Throughout, DCETTO data were analysed as has been done previously [22], using conditional 
logit models with continuous Duration and interactions between the EQ-5D level dummies and 
Duration.  Since the estimated coefficients are on a latent scale, they are unanchored and not 
directly comparable across models.  For this, anchored coefficients representing decrements 
from full health on a scale with 1 for full health and 0 for dead are necessary.  The main results 
are reported in terms of the anchored coefficients, and the unanchored coefficient are reported 
in the Appendices.
To investigate the effects of changing the ordering of dimensions (aim a), we first examined 
hypothesis a1 through the distribution of self-reported EQ-5D-5L health across the samples for 
Type III and Types IIIa to IIId.  Regarding health state values (hypothesis a2), we compared the 
anchored coefficients between Types estimated from the separate models. Next, we replicated 
the analysis by Kjaer et al [14] by pooling the data across all the Types and incorporating 
interaction variables with the explanatory variables of the unanchored model multiplied by a 
dummy variable indicating the different Types. Given the number of variables, we focussed on 
the level-5 dimensions and the Duration attribute only. If the interaction variable with Type is 
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statistically N" it will show that the different design has influenced that parameter 
estimate.
To address the effects of splitting composite dimensions (aim b), self-reported health was 
compared between Type III and Types IVa and IVb, to examine the distributions of self-reported 
PD in Type III alongside self-reported Pain and Discomfort in Type IVa; and similarly for AD 
(hypothesis b1).  Furthermore, to test hypothesis b2, DCETTO data were modelled by sub-Type 
and compared to the Type III model.  In particular, the size of the split coefficients (anchored) 
was compared with the corresponding composite coefficients.
To examine the effects of bolting off EQ-5D dimensions (aim c) to test hypotheses c1 and c2, a 
procedure similar to the one described above for hypotheses a1 and a2 was followed.
Results
Response rate and demographics
The analysis uses data from 2,494 respondents who completed the survey.  Of these, 700 
answered the baseline Type III DCETTO survey; 600 answered one of four sub-Types (IIIa to IIId) 
addressing aim (a); 450 answered one of two sub-Types (IVa and IVb) addressing aim (b); and 
just under 750 answered one of five sub-Types (Va to Ve) addressing aim (c).  For details of the 
sample characteristics, see Table 1.
Results of aim (a)
Figure 1 illustrates the distribution of self-reported EQ-5D, by the samples for Types III and IIIa 
to IIId.  The three panels on the left are for M, SC and UA, and the bar charts indicate the 
proportion of respondents at levels 1 to 5.  The charts show that there are some deviations 
from Type III.  However, across the four different orderings tested, none of the variations 
observed are explained by appearing first or last, and thus hypothesis a1 cannot be rejected.
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Table 2 reports anchored coefficients of the DCETTO models.  Looking along the rows, the largest 
decrement for four coefficients (M3, M5, SC3, UA3 and AD3) fall on IIId where Duration appears 
first, while it never falls on a dimension appearing first.  Neither does the smallest decrement 
fall where the dimension appears first.  The largest decrement appears last (just before 
Duration) only in III (AD3, but not AD5).  The consistently smaller standard error when Duration 
is presented first (IIId) suggests that rearranging the EQ-5D dimensions can have larger impacts 
than the placing of Duration in the choice task.  
Table 3 summarises the results of the Kjaer et al analysis incorporating interactions with the 
design variables (e.g. IIIa x M5xD), and using Type III as the baseline.  All the data are pooled.  
The Duration dimension does not have significant design-interactions (other than IIIa x D), 
suggesting robustness amongst the four different orderings tested here.  The M5 coefficient is 
the most vulnerable to ordering rearrangements amongst the level-5 coefficients, and its 
decrement inflated, except for when Duration appears first (IIId).   Regarding hypothesis a2, this 
cannot be rejected.  There is no clear pattern to be seen that can be explained with reference 
to serial position effects.
Results of aim (b)
Table 4 cross tabulates self-reported Pain, Discomfort, Anxiety and Depression using data from 
the samples for Types IVa, IVb and III.  Since there are no statistically significant differences in 
self-assessed health across the samples and the other background characteristics are similar (cf. 
Table 1), it is reasonable to assume that underlying health across the samples is also similar.  
Taking the EQ-5D-5L wording at face value, only those with no Pain or Discomfort should report 
level 1 PD.  From Type IVa in Table 4(a), this proportion is 51.6% (cell highlighted in dark grey), 
while the proportion observed in Type III in Table 4(c) is 56.9% (cell in dark grey; p = 0.148, z-
test).  Similarly, only those with no Anxiety or Depression should report level 1 AD.  From Type 
IVb in Table 4(b), this proportion is 44.9% (cell in light grey), while the proportion observed in 
Type III in Table 4(c) is 57.3% (cell in light grey; p = 0.001).  Thus, hypothesis b1 cannot be 
rejected for PD, but is rejected for AD.
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Table 5 presents the anchored coefficient. Regarding PD, the level 3 and level 5 composite 
coefficients in Type III are larger in magnitude than the corresponding sub-domain coefficients 
in Type IVa for Pain (one-sided p = 0.307 for level 3, p = 0.139 for level 5); and similarly for 
Discomfort ( p = 0.307 for level 3, p < 0.001 for level 5).  Regarding AD, the composite 
coefficients in Type III are larger in magnitude than the corresponding coefficients in Type IVb 
for Anxiety (p = 0.141 for level 3, p < 0.001 for level 5); but smaller for Depression (p = 0.093 for 
level 3, p = 0.119 for level 5).  Thus, hypothesis b2 is not rejected for any of the level 3 
coefficients; for the level 5 coefficients, it is rejected for PD (relative to Pain) and AD (relative to 
Anxiety).  
Results of aim (c)
Figure 2 illustrates the distribution of self-reported levels of each of the (relevant) EQ-5D 
dimension, by the samples for Types III and Va to Ve.  The EQ-5D-5L dimensions bolted off 
appear as blank spaces.  The charts show that there are variations in self-reported EQ-5D-5L 
problems across the bolt-off Types, but none of these are statistically significant from Type III 
(z-test at 5%).  Thus, hypothesis c1 cannot be rejected.
Table 6 presents the anchored coefficients.  Of the 36 significant anchored coefficients amongst 
the five Type V models, 33 of them are larger in the bolt-off model than the corresponding 
coefficient in Type III.  Type Vd (bolting off PD) is the exception and has two level-3 coefficients 
that are non-significant (M3, SC3) and two coefficients that are smaller than the corresponding 
Type III coefficient (M5, UA5).  Table 7 summarises the results of the Kjaer et al analysis 
incorporating interactions with the design variables (e.g. Vb x M5xD), using Type III as the 
baseline and therefore omitted; also omitted are the coefficients for the dimension that is 
bolted off in each Type (e.g. interaction of Va and M5xD is omitted).  The results show that first, 
all the significant coefficients are negative; second, the M5 coefficient is not significantly 
affected by other dimensions being bolted off, but the other coefficients are; third, SC5, US5 
and PD5 are affected more than AD5; and finally, Duration is not affected.  Thus, hypothesis c2 
is rejected: with the exception of Mobility, the disutilities of the dimensions are affected by 
another dimension being bolted off.
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Discussion
This paper examines the effects of: (a) varying the order in which EQ-5D(-5L) dimensions are 
presented; (b) splitting up the two composite EQ-5D dimensions (PD and AD); and (c) bolting off 
one EQ-5D dimension at a time.  The effects were examined in two contexts: (1) self-reporting 
own health; and (2) health state valuation using DCETTO.  An online survey using a commercial 
internet panel was conducted in the UK with 2,494 respondents. 
Regarding hypothesis a1 (the proportion of people reporting level 1 in a given dimension is not 
affected by whether the dimension appears first or last), and hypothesis a2 (the disutility of a 
dimension is unaffected by whether it is presented first or last), neither of these can be rejected 
by out data.  While both self-reported health and health state values varied significantly by the 
order in which the EQ-5D-5L dimensions are presented, these cannot be explained with respect 
to the serial position effects.  The study has only examined four orderings out of the possible 
240 permutations (two Duration dimension positions, with 120 EQ-5D-5L dimension orderings), 
and the effect of the position may have interacted with the dimension itself.  For health state 
valuation, the significant variations appear to contradict Mulhern et al [12] which randomised 
all 120 possible permutations of the five dimensions both within and between respondents 
(with Duration always last) and found no significant effect of dimension ordering in a DCETTO.  
However, Mulhern et al [12] examined the effect of the position of a dimension (independently 
of the other four dimensions), whereas this study examined the effect of the ordering 
(permutations) of the dimensions. (Mulhern et al [12] did not analyse self-reported health.)
Hypothesis b1 (the proportion of people who self-report level 1 in a composite dimension is no 
different from the proportion of people who self-report level 1 in both sub-dimensions when 
the dimension is decomposed) cannot be rejected for Pain or Discomfort, but is rejected for 
Anxiety or Depression.  In other words, the PD dimension appears to be interpreted more 
literally than the AD dimension.  It would be interesting to see if this holds for non-English 
versions of EQ-5D.
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Hypothesis b2 (the disutility associated with a composite dimension is no larger than the 
disutility associated with either sub-dimension at the same level) is not rejected for any of the 
level 3 coefficients, but is rejected for the level 5 coefficients (PD relative to Pain, and AD 
relative to Anxiety).  Specifically, what respondents have in mind when valuing extreme Pain or 
Discomfort is significantly worse than extreme Discomfort on its own, and what respondents 
have in mind when valuing extreme Anxiety or Depression is significantly worse than extreme 
Anxiety on its own.      
Imagine a patient with extreme problems in all the dimensions: Table 5 reports the predicted 
values in the last row.  Compared to Type III (EQ-5D-5L), Type IVa (splitting PD) results in a 
health state value that is milder by 0.099, while Type IVb (splitting AD) results in a value that is 
more severe by 0.118.  These are substantial differences.  To give some context, a recent study 
has calculated the minimally important difference for EQ-5D-5L across six countries and found 
them in the region of 0.037 to 0.069 [25], while the differences observed here are an order of 
magnitude larger.  
This has major implications for EQ-5D-5L, and beyond.  In effect, a given EQ-5D-5L profile may 
mean different things depending on whether the profile is used to self-report ones health or to 
value hypothetical states, so that the health state values EQ-5D-5L in population tariffs may not 
correspond to the states that patients self-report themselves in.  Furthermore, since our study 
has used an adapted version of EQ-5D-5L with levels 1, 3, and 5 only, the three-level version of 
EQ-5D is highly likely to be susceptible to the same effect.  Taken at face value, our results 
would suggest economic evaluation that use EQ-5D(-5L) are systematically biased.  Establishing 
the robustness of the findings using other valuation methods, to gauge the size and direction of 
the error in terms of health gains (as opposed to values for health states) is a research priority.   
In addition, a composite dimension brings together items that are thought to be similar or 
related to each other, and if so, splitting them would, in effect, create two dimensions that 
violate independence.  Given this, simply splitting the composite dimension(s) is unlikely to be 
the best solution.  Further research on splitting-and-dropping items may be informative.
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Regarding hypothesis c1 (the proportion of people reporting problems in a dimension is 
unaffected by another dimension being bolted off), this cannot be rejected.  The effect of 
dropping an EQ-5D dimension on the other dimensions seemed to be relatively small, and none 
were significant.  However, hypothesis c2 (the disutility of a dimension is unaffected by another 
dimension being bolted off) is rejected: the absence of a dimension was found to affect the 
values of the remaining dimensions other than Mobility, while the value of survival in full health 
remained unaffected.  
To place this in context, the lower rows of Table 6 reports predicted values.  With the exception 
of Type Vd (drop PD), the worst states in the bolt-off instrument (with four extreme 
dimensions) resulted in more severe predicted values than the corresponding EQ-5D-5L (with 
four extreme problems)  and the differences between corresponding states are an order of 
magnitude larger than the minimum importance difference referenced above  the implication 
is that when respondents value a health state, they do not assume that everything else not 
mentioned by the descriptive system is fine. Indeed (with the exception of Type Vd), the worst 
states in the bolt-off instrument (with four extreme dimensions) had predicted values that were 
worse than 55555 with five extreme dimensions (-0.774, Type III).  
While similar findings have been observed in the bolt-on literature, this is inconsistent with the 
practice in typical health state valuation exercises (including the present study) instructing 
respondents to imagine that there are no further health problems beyond what is explicitly 
mentioned in the hypothetical health state to be valued.  The results reinforce the possibility 
that respondents make their own inferences about problems in the unmentioned dimensions of 
health.  This adds to the growing evidence on the non-independence of bolt-on items, and 
more generally on how respondents to health state valuation tasks supplement the minimal 
description of the hypothetical health states with their own concepts.  These call for better 
ways of informing the respondents about the hypothetical health states they are valuing, and 
perhaps probing the respondents about those states afterwards, rather than simply presenting 
them with short abstract health state descriptions.
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The study has a few limitations.  The first concerns the use of DCETTO, which is not the valuation 
method used in the recommended protocol for valuing EQ-5D-5L [26].  Because this is an 
ordinal method that relies heavily on econometric modeling and its assumptions, there may be 
concerns over the validity of the anchored values produced.  However, the aim of this study is 
entirely methodological and does not aim to produce a population tariff.  Furthermore, the 
experimental versions of EQ-5D are compared against the reference that is also valued within 
the same study using DCETTO, without involving cross-method or cross-study comparisons.  Of 
course, the design does not rule out the possibility that DCETTO is particularly vulnerable to, for 
example, splitting composite dimensions.  And therefore it would be of major interest to see 
whether the findings hold for the composite Time Trade-Off method, and in face-to-face 
interviews [26].  The second would be the use of an online survey recruiting respondents from a 
commercial internet panel.  The pros and cons of online surveys relative to face-to-face 
interviews in the context of health state valuations have been discussed elsewhere [27], and 
include the substantially lower costs, the speed of data collection, the absence of interviewer 
effects, alongside the exclusion of certain populations and possible lack of respondent 
engagement.  The same study has, however, found that in terms of binary choice behaviour, 
online surveys and interview surveys do not differ in terms of binary choice behaviour of the 
kind used in DCETTO.  And finally, the study was conducted in the UK using the English version of 
the EQ-5D-5L  the results may or may not hold in different language versions or populations 
beyond the UK.
To conclude, the paper reports on a study that examined effect of manipulating the EQ-5D 
health state classification system in three different ways (change dimension ordering; split 
composite dimensions; bolt-off one dimension at a time) across two contexts (self-reporting 
health and health state valuation).  The values given to certain health dimensions are sensitive 
to the way in which it is described, and the other health dimensions presented. Of particular 
interest concerns how the composite dimensions are interpreted differently across self-
reporting and health state valuation  this raises questions about the validity of EQ-5D(-5L) in 
economic evaluation.
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1Table 1: Completion and demographics for all Types
Type III 
(n,%)
Type IIIa 
(n,%)
Type IIIb 
(n,%)
Type IIIc 
(n,%)
Type IIId 
(n,%)
Type IVa 
(n,%)
Type IVb 
(n,%)
Type Va 
(n,%)
Type Vb 
(n,%)
Type Vc 
(n,%)
Type Vd 
(n,%)
Type Ve 
(n,%)
Completion process
Invited 5247 1583 1341 1220 1079 1597 1610 1147 1189 1247 1369 1270
Accessed1 1098 (20.9) 225 (14.2) 232 (17.2) 223 (18.3) 242 (22.4) 377 (23.6) 392 (24.3) 251 (21.7) 230 (19.3) 235 (18.8) 244 (17.8) 251 (19.8)
Not consent/pass info2 361 (32.9) 63 (28.0) 71 (5.3) 63 (28.2) 85 (35.1) 141 (37.4) 155 (39.5) 96 (8.4) 77 (33.5) 80 (34.00 84 (34.4) 96 (38.2)
Drop out during survey2 36 (3.3) 11 (4.8) 9 (3.9) 10 (4.4) 7 (2.9) 11 (2.9) 12 (3.1) 5 (2.0) 7 (3.0) 4 (1.7) 10 (4.0) 5 (2.0)
Complete < 2 mins2 1 (0.1) 0 2 (0.8) 0 0 0 0 2 (0.8) 0 1 (0.4) 0 0
Full completer2 700 (63.8) 150 (66.7) 150 (64.7) 150 (67.3) 150 (62.0) 225 (59.7) 225 (57.4) 148 (59.4) 146 (63.5) 150 (63.8) 150 (61.5) 150 (59.8)
Obs per block (6 in each 
Type)
103-132 16-34 22-27 14-31 23-28 29-50 29-48 21-35 20-28 16-38 16-38 18-33
Demographics
Male 340 (48.6) 72 (48.0) 73 (48.7) 71 (47.3) 69  (46.0) 102 (45.3) 108 (48.0) 73 (49.3) 69 (47.2) 73 (48.7) 75 (50.0) 72 (48.0)
Age (m) 41.5 42.9 41.8 41.5 42.1 42.3 42.6 41.02 41.1 42.7 41.7 42.6
Age (range) 18-65 18-73 17-65 18-65 18-65 18-65 18-65 18-74 18-65 18-66 18-65 18-65
Married/partner 390 (55.8) 90 (60.0) 79 (52.7) 86 (56.9) 88 (58.7) 129 (57.3) 141 (62.7) 88 (59.4) 90 (61.6) 95 (63.3) 91 (60.7) 93 (62.0)
In employment 462 (66.1) 90 (60.0) 96 (64.0) 99 (66.0) 93 (62.0) 148 (65.8) 154 (68.4) 98 (65.3) 97 (66.4) 100 (66.6) 99 (66.0) 96 (64.0)
Education past min age 585 (83.6) 128 (85.3) 125 (83.3) 126 (84.0) 120 (80.0) 184 (81.8) 202 (89.8) 121 (81.8) 127 (87.0) 122 (81.3) 133 (88.7) 123 (82.0)
Degree 389 (56.3) 83 (55.3) 87 (58.0) 78 (52.0) 76 (50.7) 105 (46.7) 132 (58.7) 80 (54.1) 88 (60.3) 85 (56.7) 87 (58.0) 77 (51.3)
Self-assessed health
Good/very good/excellent 570 (82.1) 126 (84.0) 115 (76.7) 120 (80.0) 121 (80.7) 187 (83.1) 182 (80.9) 123 (83.1) 121 (82.9) 125 (83.3) 119 (79.4) 117 (78.0)
Fair/Poor 128 (17.9) 24 (16.0) 35 (23.3) 30 (20.0) 29 (19.3) 38 (16.9) 43 (19.1) 25 (16.9) 25 (17.1) 25 (16.7) 31 (20.6) 33 (22.0)
1  Percentage of those invited to take part; 2  Percentage of those accessing the survey
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1Tabl     I and 	-variants with different ordering (anchored)
III IIIa (SC-UA-PD-
AD-M)
IIIb (PD-AD-M-
SC-UA)
IIIc (AD-PD-UA-
SC-M)
IIId (Duration 
first)
Coef SE Coef SE Coef SE Coef SE Coef SE
M3 -0.081 0.044 -0.130 0.102 -0.076 0.099 -0.079 0.101 -0.142 0.083
M5 -0.355 0.046 -0.303 0.104 -0.273 0.100 -0.295 0.104 -0.393 0.088
SC3 -0.076 0.042 -0.060 0.099 -0.022 0.095 -0.088 0.098 -0.119 0.083
SC5 -0.307 0.045 -0.332 0.111 -0.297 0.100 -0.337 0.104 -0.334 0.084
UA3 -0.091 0.042 -0.093 0.095 -0.092 0.094 -0.119 0.097 -0.122 0.086
UA5 -0.246 0.044 -0.269 0.101 -0.243 0.096 -0.224 0.100 -0.243 0.085
PD3 -0.091 0.045 -0.117 0.100 -0.051 0.100 -0.043 0.104 -0.087 0.082
PD5 -0.452 0.050 -0.497 0.115 -0.465 0.112 -0.397 0.116 -0.381 0.087
AD3 -0.104 0.043 -0.083 0.098 -0.103 0.096 -0.091 0.099 -0.117 0.080
AD5 -0.414 0.048 -0.464 0.115 -0.389 0.103 -0.419 0.111 -0.350 0.084
NB. Unanchored coefficients and SE in Table A1 in the Appendix. 
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Tab
   effect of changing the ordering on specc C
TT
 attribtes
Pled
 Coef. 
IIIa x M5xD 00ﬀﬁ 0.013
IIIb x M5xD 00ﬀﬂ 0.007
IIIc x M5xD 00ﬁﬃ 0.033
IIId x M5xD -00ﬁ 0.042
IIIa x SC5xD -00ﬀ 0.002
IIIb x SC5xD -0.021 0.082
IIIc x SC5xD -0.023 0.056
IIId x SC5xD -0.007 0.543
IIIa x UA5xD -00ﬀﬀ 0.012
IIIb x UA5xD -0.023 0.068
IIIc x UA5xD -0.001 0.911
IIId x UA5xD 0.002 0.871
IIIa x PD5xD -00ﬁ 0.039
IIIb x PD5xD -
00ﬀ0
0.020
IIIc x PD5xD 0.007 0.574
IIId x PD5xD 00ﬂ! 0.000
IIIa x AD5xD -00ﬁ! 0.046
IIIb x AD5xD 0.009 0.464
IIIc x AD5xD 0.012 0.335
IIId x AD5xD
00ﬂﬃ
0.000
IIIa x D
00ﬀﬀ
0.014
IIIb x D 0.013 0.300
IIIc x D -0.008 0.513
IIId x D -0.015 0.244
No of respondents 1300
No of choices 13000
Log Likelihood -9120
NB1. Coefficients with p < 0.05 in bold.
NB2. All models controls for Duration and for two-way interactions between Dimension-level and 
Duration.  All controls are significant at the 0.001 level.  Full results available from the authors on 
request.
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1Table 4: Distribution of self-re"#$%e& '()n* +),.#/1ort* 2n3)e%4 (nd De"ression
(a) Pain a
n& +),.#/1
ort
* 54"e 67( ,(/"8e 9n:;<=>
Pain
?@AB DEF
GH If totalJ None Any ?Ital
None 51.6 4.9 56.4
Any 4.9 38.7 43.6
D
is
co
m
fo
rt
Total 56.4 43.6 100.0
(b)
2n3)e%4
 and 
+e"$e
ssion, T
4"e 67p ,(/"8
e (
n:;<=>
AnxietyType IVb
(%of total) None Any Total
None 44.9 23.1 68.0
Any 2.2 29.8 32.0
D
e
p
re
ss
io
n
Total 47.1 52.9 100.0
(c) PainK
+),.#/1
ort and Anxiet
4
K
+e"$
ession, 5
4"e
666
,(/"
8
e
9
n
:L==>
Pain/DiscomfortType III
(% of total) None Any Total
None 40.3 17.0 57.3
Any 16.6 26.1 42.7
A
n
xi
e
ty
/
D
e
p
re
ss
io
n
Total 56.9 43.1 100.0
NB. The null hypothesis implies that the cells with the same highlights have the same 
percentages. 
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1TabMN OQ RSUN VVI and Type IV splitting the composite dimensions (anchored)
NB. Unanchored coefficients and WX YZ [able A2 in the Appendix. 
III (\]^_`ane) IVa (PD split) fgh iAD split)
j]k]m_ter Coef SE Coef SE Coef SE
oq -0.081 0.044 -0.128 0.026 -0.083 0.029
M5 -0.355 0.046 -0.287 0.029 -0.338 0.035
SC3 -0.076 0.042 -0.103 0.024 -0.057 0.026
SC5 -0.307 0.045 -0.321 0.030 -0.283 0.034
UA3 -0.091 0.042 -0.024 0.024 0.003 0.027
UA5 -0.246 0.044 -0.140 0.024 -0.188 0.029
PD3 -0.091 0.045 -0.060 0.024
PD5 -0.452 0.050 -0.401 0.038
AD3 -0.104 0.043 -0.121 0.024
AD5 -0.414 0.048 -0.400 0.034
Pa3 -0.066 0.021
Pa5 -0.387 0.033
Di3 -0.066 0.021
Di5 -0.140 0.024
An3 -0.051 0.024
An5 -0.192 0.028
De3 -0.172 0.028
De5 -0.490 0.043
33333/333333 0.557 0.492 0.580
55555/555555 -0.774 -0.675 -0.892
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1Tabrs tu vwxs yyI and Type V bolting off different z{ |}~snsions (red)
ter III (Łne)  rop M)  rop SC)  (drop UA)  rop PD)  (drop AD)
Coeff SE Coeff SE Coeff SE Coeff SE Coeff SE Coeff SE
 -0.081 0.044 -0.107 0.036 -0.082 0.039 -0.016 0.029 -0.142 0.035
M5 -0.355 0.046 -0.438 0.049 -0.388 0.050 -0.264 0.031 -0.459 0.053
SC3 -0.076 0.042 -0.110 0.034 -0.093 0.036 -0.040 0.028 -0.069 0.035
SC5 -0.307 0.045 -0.488 0.054 -0.434 0.057 -0.331 0.034 -0.367 0.046
UA3 -0.091 0.042 -0.146 0.036 -0.143 0.036 -0.100 0.028 -0.092 0.037
UA5 -0.246 0.044 -0.381 0.045 -0.369 0.045 -0.229 0.033 -0.330 0.047
PD3 -0.091 0.045 -0.133 0.039 0.006 0.036 -0.120 0.038 -0.111 0.034
PD5 -0.452 0.050 -0.520 0.057 -0.532 0.058 -0.516 0.065 -0.631 0.071
AD3 -0.104 0.043 -0.185 0.038 -0.229 0.036 -0.085 0.033 -0.189 0.029
AD5 -0.414 0.048 -0.533 0.063 -0.587 0.063 -0.481 0.063 -0.516 0.047
3333  0.426 0.527 0.620 0.655 0.586
3333

0.638 0.633 0.648 0.648 0.661
5555  -0.922 -0.926 -0.819 -0.340 -0.787
5555
 -0.419 -0.467 -0.528 -0.322 -0.360
edicted value of the corresponding state i   ¡ ¢sing the £ype III coefficients (e.g. 13333 for 3333 
in ¤¥¦ § ¨5 for 5555 i ¤©ª
NB. Unanchored coefficients and «¬ ­® ¯able A3 in the Appendix.
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Tab°± ²³ ´µ± effect of bolting off dimensions on spe¶·¸·¶ ¹º»
¼¼½
 attri¾¿tes
NB1. Coefficients with p < 0.05 in bold.
NB2. All models controls for Duration and for two-way interactions between Dimension-level and 
Duration.  All controls are significant at the 0.001 level.  Full results available from the authors on 
request.
 ÀÁÁled
 Coef. ÂÃÄ
ÅÅÅ Æ ÇÈÆÉ ÊËÌÍÍÎÏ
ÐÑ Æ ÇÈxD ÊËÌÍÍÎÏ
ÐÒ Æ ÇÈÆÉ -0.014 0.294
ÐÓ Æ ÇÈxD -0.007 0.579
ÐÏ Æ ÇÈÆÉ 0.008 0.517
Ve x M5xD -0.021 0.138
III x SC5xD Omitted
Va x SC5xD ÔÕÖÕ×Ø 0.000
Vb x SC5xD Omitted
Vc x SC5xD ÔÕÖÕÙÚ 0.002
Vd x SC5xD ÔÕÖÕÛÜ 0.023
Ve x SC5xD -0.022 0.084
III x UA5xD Omitted
Va x UA5xD ÔÕÖÕ
Ù
Ý 0.005
Vb x UA5xD ÔÕÖÕÛÜ 0.031
Vc x UA5xD Omitted
Vd x UA5xD -0.003 0.826
Ve x UA5xD ÔÕÖÕ
Û
Ø 0.037
III x PD5xD Omitted
Va x PD5xD -0.007 0.594
Vb x PD5xD ÔÕÖÕÛÜ 0.040
Vc x PD5xD -0.014 0.323
Vd x PD5xD Omitted
Ve x PD5xD ÔÕÖÕ×
Ù
0.000
III x AD5xD Omitted
Va x AD5xD -0.018 0.204
Vb x AD5xD -0.027 0.063
Vc x AD5xD -0.022 0.123
Vd x AD5xD ÔÕÖÕÞ
Û
0.002
Ve x AD5xD Omitted
III x D Omitted
Va x D -0.053 0.187
Vb x D -0.046 0.236
Vc x D -0.021 0.656
Vd x D 0.038 0.350
Ve x D -0.042 0.330
No of respondents 1,444
No of choices 14,440
Log Likelihood -6,504
Page 26 of 31
 Figure 1: Distribution of self-reported health: Types III , IIIa, IIIb, IIIc, and IIId (ordering) 
Type III: baseline 
Type IIIa: (SC-UA-PD-AD-M-D) 
Type IIIb: (PD-APD-M-SC-UA-D) 
Type IIIc: (AD-PD-UA-SC-M-D) 
Type IIId: (D-M-SC-US-PD-AD) 
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 Figure 2: Distribution of self-reported health: Types III and V (bolt-off) 
Type III: baseline 
Type Va: drop Mobility 
Type Vb: drop Self-Care 
Type Vc: drop Usual Activities 
Type Vd: drop Pain/Discomfort 
Type Ve: drop Anxiety/Depression 
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ßààáâãäåäáæ
Tabçè ßéê ëìíè ääI and subîïðñianòó ôõòö different orderi÷ø ùúna÷ûöüñèd)
Coefficients with p < 0.05 in bold.
III IIIa (SC-UA-PD-AD-M) IIIb (PD-AD-M-SC-
UA)
IIIc (AD-PD-UA-SC-
M)
IIId (Duration first)
Parameter Coef ýþ P Coef ýþ P Coef ýþ P Coef ýþ P Coef ýþ P
ßM    -0.032 0.006 0.000 -0.050 0.014 0.000 -0.028 0.013 0.024 -0.028 0.012 0.023 -0.085 0.016 0.000
M5 x D -0.140 0.006 0.000 -0.117 0.014 0.000 -0.101 0.013 0.000 -0.104 0.014 0.000 -0.235 0.017 0.000
SC3 x D -0.030 0.006 0.000 -0.023 0.014 0.097 -0.008 0.013 0.514 -0.031 0.013 0.013 -0.071 0.016 0.000
SC5 x D -0.121 0.006 0.000 -0.128 0.014 0.000 -0.110 0.013 0.000 -0.119 0.013 0.000 -0.200 0.016 0.000
UA3 x D -0.036 0.006 0.000 -0.036 0.014 0.008 -0.034 0.013 0.008 -0.042 0.012 0.001 -0.073 0.019 0.000
UA5 x D -0.097 0.006 0.000 -0.104 0.014 0.000 -0.090 0.013 0.000 -0.079 0.012 0.000 -0.145 0.016 0.000
PD3 x D -0.036 0.006 0.000 -0.045 0.014 0.001 -0.019 0.013 0.162 -0.015 0.012 0.249 -0.052 0.018 0.000
PD5 x D -0.178 0.006 0.000 -0.192 0.014 0.000 -0.172 0.013 0.000 -0.140 0.012 0.000 -0.228 0.015 0.000
AD3 x D -0.041 0.006 0.000 -0.032 0.014 0.012 -0.038 0.013 0.002 -0.032 0.013 0.006 -0.070 0.017 0.000
AD5 x D -0.163 0.006 0.000 -0.179 0.014 0.000 -0.144 0.013 0.000 -0.148 0.013 0.000 -0.209 0.016 0.000
D 0.394 0.019 0.000 0.386 0.042 0.000 0.370 0.041 0.000 0.353 0.038 0.000 0.598 0.048 0.000
No of 
respondents
700 150 150 150 150
 No of 
choices
7000 1500 1500 1500 1500
Log 
Likelihood
-3353 -688 -734 -774 -653
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1Table A2: Type III and Type IV splitting the composite dimnsions (unanchored)
III (Baseline) I PD split) I (AD split)
P	ter Coef SE P Coef SE P Coef SE P

  -0.032 0.006 0.000 -0.057 0.011 0.000 -0.033 0.011 0.003
M5x D -0.140 0.006 0.000 - 0.011 0.000 -0.134 0.011 0.000
SC3x D -0.030 0.006 0.000 - 0.011 0.000 - 0.011 0.034
SC5x D - 0.006 0.000 - 0.012 0.000 - 0.012 0.000
UA3x D - 0.006 0.000 -0.011 0.011 0.311 0.001 0.011 0.904
UA5x D -0.097 0.006 0.000 - 0.009 0.000 - 0.010 0.000
PD3x D - 0.006 0.000 - 0.010 0.018
PD5x D - 0.006 0.000 - 0.011 0.000
AD3x D - 0.006 0.000 - 0.010 0.000
AD5x D - 0.006 0.000 - 0.012 0.000
Pa3x D - 0.010 0.003
Pa5x D - 0.012 0.000
Di3x D - 0.010 0.003
Di5x D - 0.010 0.000
An3x D - 0.010 0.035
An5x D -

 0.011 0.000
De3x D - 0.010 0.000
De5x D - 0.012 0.000
T  0.019 0.000  0.035 0.000  0.035 0.000
No of respondents 700 225 225
No of choices 7000 2250 2250
Log Likelihood -3353 -1147 -1110
Coefficients with p < 0.05 in bold. 
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1Table A3: Type III and Type  lting off different ﬀﬁ ﬂﬃ!"#ﬃns (unanchored)
III (Baseline) $% &'rop () $* &'rop SC) $+ (drop UA) $' &'rop PD) $, (drop AD)
.%/%0,
ter Coef SE P Coef SE P Coef SE P Coef SE P Coef SE P Coef SE P
123 4 -0.032 0.006 0.000 -0.039 0.013 0.003 -0.031 0.015 0.037 -0.007 0.013 0.574 -0.054 0.014 0.000
153 4 -0.140 0.006 0.000 -0.159 0.014 0.000 -0.146 0.015 0.000 -0.119 0.013 0.000 -0.174 0.015 0.000
SC
23 4
-0.030 0.006 0.000 -0.042 0.014 0.002 -0.035 0.014 0.013 -0.018 0.013 0.153 -0.026 0.014 0.055
SC5x D -0.121 0.006 0.000 6789:; 0.014 0.000 -0.163 0.016 0.000 -0.149 0.013 0.000 -0.139 0.014 0.000
UA3x D -0.036 0.006 0.000 -0.056 0.014 0.000 -0.052 0.013 0.000 -0.045 0.013 0.001 -0.035 0.013 0.009
UA5x D -0.097 0.006 0.000 -0.146 0.014 0.000 -0.134 0.013 0.000 -0.103 0.013 0.000 -0.125 0.014 0.000
PD3x D -0.036 0.006 0.000 -0.051 0.015 0.001 0.002 0.013 0.868 -0.045 0.014 0.001 -0.042 0.014 0.002
PD5x D
6789;:
0.006 0.000
6789<<
0.014 0.000
6789<=
0.014 0.000
6789<>
0.015 0.000
678?=<
0.016 0.000
AD3x D
6787>9
0.006 0.000
6787;9
0.014 0.000
6787:=
0.012 0.000
6787=?
0.013 0.012
6787:@
0.013 0.000
AD5x D 6789A= 0.006 0.000 678?7> 0.016 0.000 678?9= 0.015 0.000 6789:9 0.014 0.000 678?=? 0.015 0.000
T
78=<>
0.019 0.000
78=:=
0.042 0.000
78=A=
0.038 0.000
78=;A
0.047 0.000
78>@7
0.041 0.000
78=;<
0.016 0.000
No of respondents 700 148 146 150 150 150
No of choices 7000 1480 1460 1500 1500 1500
Log Likelihood -3353 -647 -696 -658 -709 -672
Coefficients with p < 0.05 in bold. 
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